Added to YB: 2025-09-04
Pitch date: 2025-07-16
OXB.L [bullish]
Oxford Biomedica plc
+70.11%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
Market Cap
GBP 683.8M
Pitch Price
GBP 3.68
Price Target
N/A
Dividend
N/A
EV/EBITDA
-41.50
P/E
-13.63
EV/Sales
5.71
Sector
Biotechnology
Category
value
Show full summary:
Oxford Biomedica plc - $OXB.L
OXB.L: Viral vector CDMO for CGT market, manufacturing Novartis Kymriah + likely Legend/J&J CARVYKTI. Targeting >35% revenue CAGR 2023-26, 20% EBITDA margins by 2026E. Trading 2.3x 2025E sales vs peers at 6-12x. 48 programs across 35+ clients, £570M pipeline. Risks: LNP competition, CGT market skepticism.
Read full article (6 min)